Use of leukocyte-poor blood components in acute myeloblastic leukemia does not affect disease-free survival in first complete remission.
- Published Article
British journal of haematology
- Publication Date
Sep 01, 1990
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/02/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/2223643